What medicine is Rozebalamin (methylcobalamin)?

Rozebalamin (methylcobalamin) is an active form of vitamin B12 and is commonly used to treat various neurological disorders caused by vitamin B12 deficiencies. It is produced in Japan by Eisai Co., Ltd. and is approved to treat amyotrophic lateral sclerosis (ALS), helping patients manage the disease by slowing the progression of dysfunction.

Main features:

Drug ingredients:RozebalaminIt is methylcobalamin, which is the active form of vitamin B12. Compared with common cyanocobalamin, it has stronger biological activity.

Mechanism of action: It supports nerve function by participating in the repair and regeneration of nerve cells, and contributes to the normal metabolism of the nervous system. Methylcobalamin has a protective effect on the nervous system and can promote the health of nerve cells, especially repairing damaged or degenerated nerves.

Clinical application:

Amyotrophic lateral sclerosis (ALS): in2024year9month24, Rozebalamin (methylcobalamin) was approved by the Japanese authorities for marketing, specifically for the treatment of ALS. ALSis a progressive neurodegenerative disease that often results in a progressive loss of motor neuron function, leading to muscle weakness and atrophy. Rozebalaminhelps improve patients’ quality of life by slowing the progression of nerve damage.

VitaminB12 Deficiency: Methylcobalamin is widely used to treat neuropathy, anemia and other symptoms caused by vitamin B12 deficiency. It is suitable for patients with vitamin B12 Deficiency causes peripheral neuropathy and other neurological disorders.

Main therapeutic effects:

Nerve repair effect: It can promote the repair of nerve damage, especially for peripheral neuropathy caused by vitamin B12 deficiency.

Improves Metabolism: Supports normal metabolism of the nervous system and helps maintain healthy nerve and red blood cell function.

Side effects:

Methylcobalamin is generally well tolerated and has fewer side effects. Occasionally, allergic reactions, rashes, nausea and other uncomfortable symptoms may occur, but these adverse reactions are relatively rare.

Route of administration:

Oral administration: common in vitamin B12 deficiency supplements.

Injections: For more rapid or efficient vitamin supplementationB12, especially for treating neuropathy.

Rozebalamin (methylcobalamin) is an effective neuroprotective drug that has been approved in Japan for the treatment of ALS and has good effects on neuropathy and diseases related to vitamin B12 deficiency. It provides a new treatment option for ALS patients and is expected to play an important role in delaying disease progression and improving quality of life.

xa0

References:

[1]https://pins.japic.or.jp/pdf/newPINS/00071540.pdf

[2]https://www.eisai.com/news/2024/news202487.html